Is Microbot Medical Inc. (MBOT) Halal?

NASDAQ Healthcare United States $161M
✓ HALAL
Confidence: 95/100
Microbot Medical Inc. (MBOT) is Halal under 3 of 5 Shariah screening standards, including AAOIFI Standard 21. With a debt ratio of just 0.1% against the AAOIFI threshold of 30%, Microbot Medical Inc. comfortably passes the key financial ratio tests. The company operates in the Healthcare sector (Medical Instruments & Supplies), which is not a prohibited industry under Islamic finance principles.

Shariah Screening — 5 Standards

Based on financial data from December 2024

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 0.1%
/ 30%
3.4%
/ 30%
0.2%
/ 30%
N/A ✓ HALAL
DJIM 0.1%
/ 33%
3.4%
/ 33%
0.2%
/ 33%
N/A ✓ HALAL
MSCI 1.8%
/ 33%
90.7%
/ 33%
5.0%
/ 33%
N/A ✗ NOT HALAL
S&P 0.1%
/ 33%
3.4%
/ 33%
0.2%
/ 33%
N/A ✓ HALAL
FTSE 1.8%
/ 33%
90.7%
/ 33%
5.0%
/ 50%
N/A ✗ NOT HALAL

Financial Highlights

EPS
$-0.29
P/B Ratio
2.0
EV/EBITDA
-6.9
EV: $97M
Revenue
$0
Beta
1.2
High volatility
Current Ratio
27.5

Profitability

Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
Return on Equity (ROE) -31.9%
Return on Assets (ROA) -20.2%

Cash Flow & Balance Sheet

Operating Cash Flow-$9M
Free Cash Flow-$9M
Total Debt$111,000
Debt-to-Equity1.1
Current Ratio27.5
Total Assets$6M

Price & Trading

Last Close$2.62
50-Day MA$2.25
200-Day MA$2.57
Avg Volume2.0M
Beta1.2
52-Week Range
$1.35
$4.67

About Microbot Medical Inc. (MBOT)

CEO
Mr. Harel Gadot
Employees
20
Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Exchange
NASDAQ
Market Cap
$161M
Currency
USD

Microbot Medical Inc. is a medical device company that focuses on transforming endovascular procedures through advanced robotic technology. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is Microbot Medical Inc. (MBOT) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), Microbot Medical Inc. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is Microbot Medical Inc.'s debt ratio?

Microbot Medical Inc.'s debt ratio is 0.1% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 1.8%.

What are Microbot Medical Inc.'s key financial metrics?

Microbot Medical Inc. has a market capitalization of $161M. Return on equity stands at -31.9%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.